Evidence map›Paper›PMID 22227520›Full record

ArticleThe EMBO journal2012

The architecture of functional modules in the Hsp90 co-chaperone Sti1/Hop.

Andreas B Schmid, Stephan Lagleder, Melissa Ann Gräwert, Alina Röhl, Franz Hagn, Sebastian K Wandinger, Marc B Cox, Oliver Demmer, Klaus Richter, Michael Groll and 2 more

Abstract read
In one paragraph

Article in The EMBO journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 225 citations in OpenAlex.

  1. Article
  2. Hsp90: A means to an end.Cell stress & chaperones · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Recent insights into HSP70: proteostasis and beyond.Frontiers in molecular biosciences · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Strategies that regulate LSD1 for novel therapeutics.Acta pharmaceutica Sinica. B · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Detecting Posttranslational Modifications of Hsp90 Isoforms.Methods in molecular biology (Clifton, N.J.) · 2023
    Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Andreas B SchmidDepartment Chemie, Center for Integrated Protein Science (CIPSM), Technische Universität München, Garching, Germany.
Stephan Lagleder
Melissa Ann Gräwert
Alina Röhl
Franz Hagn
Sebastian K Wandinger
Marc B Cox
Oliver Demmer
Klaus Richter
Michael Groll
Horst Kessler
Johannes Buchner
Center for Integrated Protein Science Munich · DETechnical University of Munich · DEInstitute for Advanced Study · DE

Funding

TOXICOLOGY PROJECTG12RR008124 · NCRR · UNIVERSITY OF TEXAS EL PASO · PI WALSH, ELIZABETH J · 1992 to 2011
$20.8M
NCRR NIH HHS 5G12RR008124NCRR NIH HHS G12 RR008124
6 · The paper itself

Abstract

Sti1/Hop is a modular protein required for the transfer of client proteins from the Hsp70 to the Hsp90 chaperone system in eukaryotes. It binds Hsp70 and Hsp90 simultaneously via TPR (tetratricopeptide repeat) domains. Sti1/Hop contains three TPR domains (TPR1, TPR2A and TPR2B) and two domains of unknown structure (DP1 and DP2). We show that TPR2A is the high affinity Hsp90-binding site and TPR1 and TPR2B bind Hsp70 with moderate affinity. The DP domains exhibit highly homologous α-helical folds as determined by NMR. These, and especially DP2, are important for client activation in vivo. The core module of Sti1 for Hsp90 inhibition is the TPR2A-TPR2B segment. In the crystal structure, the two TPR domains are connected via a rigid linker orienting their peptide-binding sites in opposite directions and allowing the simultaneous binding of TPR2A to the Hsp90 C-terminal domain and of TPR2B to Hsp70. Both domains also interact with the Hsp90 middle domain. The accessory TPR1-DP1 module may serve as an Hsp70-client delivery system for the TPR2A-TPR2B-DP2 segment, which is required for client activation in vivo.

Indexed as

Adenosine TriphosphatasesBinding SitesHeat-Shock ProteinsHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsModels, MolecularMolecular ChaperonesOncogene Protein pp60(v-src)Protein BindingProtein Structure, SecondaryProtein Structure, TertiaryReceptors, GlucocorticoidSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAdenosine TriphosphatasesHeat-Shock ProteinsHSP70 Heat-Shock ProteinsHSP82 protein, S cerevisiaeHSP90 Heat-Shock ProteinsMolecular ChaperonesOncogene Protein pp60(v-src)Receptors, GlucocorticoidSaccharomyces cerevisiae ProteinsSSA3 protein, S cerevisiaeSTI1 protein, S cerevisiae

Identifiers

PMID22227520
PMCPMC3321170
OpenAlexW2148483912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.